Oncothyreon Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Silver Knife who wrote (812)	5/18/1999 9:26:00 AM
From: Claude Robitaille	Read Replies (1) of 2344

Globe says Biomira decline a classic story Biomira Inc BRA Shares issued 44,000,000 May 17 close $7.00 Tue 18 May 99 In the News The Globe and Mail reports in its Tuesday, May 18, edition that Biomira retreated 80 cents to $7 yesterday on the Toronto Stock Exchange. The Globe's Market Movers column reports that Levesque Beaubien Geoffrion analyst Michael Jams sees Biomira's decline as a classical case of the old stock market adage, buy on rumour and sell on news. He says investors had been pushing the stock price up recently in expectation of good news about the company's clinical results for its Theratope cancer vaccine. When the news came Saturday, it was good. Biomira said results suggest the vaccine may raise survival rates and decrease the possibility of relapse in ovarian and breast cancer patients after autologous stem cell transplants.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next